← Back to Stock Screener← Stock Screener

ZYBERNO

Stock Report

Updated Aug 22, 2026

Definitive Healthcare Corp. (DH)

Technology • NASDAQ

$0.71

Professional Investment Analysis

ZYBERNO SCORE →

Is it a great business? Is it getting better?

31.0/100

WEAK BUSINESS

Definitive Healthcare Corp. (DH) scores 31/100 — weak fundamentals with mixed indicators requiring careful analysis before acting.

📊 How is the Zyberno Score calculated? +

The Zyberno Score answers one question: "Is this a quality business worth owning?" It's a 0-100 investment grade that evaluates business fundamentals across four critical dimensions, based on principles from Warren Buffett, Benjamin Graham, Peter Lynch, and Charlie Munger.

The 4 Core Categories (25 points each):

1. PROFITABILITY (25 pts)

Metrics: ROE, ROIC, Net Margin, Operating Margin
Thresholds: ROE >20% excellent • ROIC >20% excellent • Net Margin >20% excellent • Operating Margin >25% excellent

2. FINANCIAL STRENGTH (25 pts)

Metrics: Debt-to-Equity, Current Ratio, Interest Coverage, Altman Z-Score
Thresholds: D/E <0.3 excellent • Current Ratio >2.5 excellent • Interest Coverage >10x excellent • Altman Z >3.0 safe

3. CASH FLOW QUALITY (25 pts)

Metrics: Free Cash Flow, OCF vs Net Income, FCF Margin
Thresholds: Positive & growing FCF excellent • OCF/NI >1.2x excellent (cash earnings exceed accounting)

4. GROWTH & CONSISTENCY (25 pts)

Metrics: Revenue Growth, Net Income Growth, FCF Growth, Piotroski F-Score
Thresholds: Growth via log-linear regression • Piotroski 8-9 excellent, 6-7 good

Score Interpretation:

75-100

GREAT BUSINESS

65-74

GOOD BUSINESS

50-64

AVERAGE BUSINESS

30-49

WEAK BUSINESS

0-29

POOR BUSINESS

→ View full DH quality analysis & detailed breakdown

VALUATION SIGNAL

MARGIN OF SAFETY

Is this stock cheap or expensive relative to what the business has historically generated for owners?

+77.5%

Undervalued

Growth gap unavailable — insufficient data for reverse DCF calculation.

🎯 Expected Annual Return →

38.3%

Margin of Safety convergence — your return if the market re-prices to intrinsic value (5-yr annualised)

29.2%

Yield + growth — what the business alone earns you, even if the market never re-rates

💰 How is Margin of Safety calculated? +

Margin of Safety measures how much discount or premium you're paying relative to a stock's intrinsic value. It's Benjamin Graham's core principle: the larger the margin, the lower your downside risk.

Formula: (Intrinsic Value − Current Price) ÷ Intrinsic Value × 100%

How We Calculate Intrinsic Value (DCF Method):

Step 1: Calculate current Owner Earnings (OCF − Maintenance CapEx)

Step 2: Calculate company-specific growth rate using log-linear regression on 16 quarters of Owner Earnings

Step 3: Project 10 years forward using the calculated growth rate

Step 4: Discount each year's cash flow to present value using 10% discount rate

Step 5: Calculate terminal value using 3% perpetual growth rate

Step 6: Sum all discounted cash flows = Intrinsic Value

What The Percentages Mean:

+50% or more

EXCELLENT — Very undervalued

+25% to +50%

GOOD — Attractive discount

0% to +25%

FAIR — Reasonable value

0% to -25%

CAUTION — Slight premium

-25% or worse

POOR — Overvalued

"Price is what you pay, value is what you get." — Warren Buffett

→ View full DH valuation analysis · → View full DH Brina Gap analysis

📈 How is Brina Gap calculated? +

Brina Gap measures the difference between the growth a business can fundamentally sustain and the growth the market is already pricing in.

Formula: Fundamental Growth Rate − Market-Implied Growth Rate

The Two Components:

Fundamental Growth Rate = ROIC × Reinvestment Rate

What the business can sustainably grow at based on how much it reinvests and what return it earns on that capital. Grounded in historical financials.

Market-Implied Growth Rate = Reverse DCF

The growth rate the current Enterprise Value implicitly assumes. Calculated by back-solving a 10-year DCF model (10% WACC, 3% terminal growth) until the present value of projected cash flows equals EV.

What The Gap Means:

Gap > +5% Market Underestimates — potential upside

+2% to +5% Slight Underestimate

-2% to +2% Fairly Priced — market consensus matches fundamentals

-5% to -2% Slight Overestimate

Gap < -5% Market Overestimates — price embeds optimism fundamentals don't support

A positive gap (market underestimates) combined with a positive Margin of Safety is the strongest combined signal — the business is both cheap historically and forward economics are stronger than the price suggests.

Critical Financial Health Indicators

Return on Equity (Profitability):CRITICAL (-58.6%)

Debt-to-Equity (Solvency Risk):EXCELLENT (0.08x)

Operating Margin (Operational Efficiency):CRITICAL (-104.6%)

Return on Capital (Capital Efficiency):CRITICAL (-102.7%)

📊 Valuation Trilogy

Three interconnected metrics for complete valuation analysis

Click any metric for full methodology and detailed analysis

Zyberno's Verdict

Definitive Healthcare Corp. (DH) stock report — Zyberno Score 31/100 (WEAK BUSINESS), Margin of Safety +77.5%, 38% expected annual return. Full financial analysis on Zyberno.

According to Zyberno's DCF model, Definitive Healthcare Corp. (DH) trades at $0.71 against an estimated intrinsic value per share of $3.17 — a +77.5% Margin of Safety based on Owner Earnings of $27.06M TTM, projected at 0.5% growth for 10 years with a 2.5% terminal growth rate. Zyberno's model translates this into a 5-year expected return of 38.3% annually.

Over the trailing twelve months, DH generated $27.06M in Owner Earnings. Capital was deployed as follows: $12.22M invested in capital expenditures. Reinvestment rate: 10.5%. Owner Earnings have grown at 0.5% annually over the trailing five years using log-linear regression.

DIVISION I: EXECUTIVE SUMMARY

A. Market Valuation

Market Price & Capitalization (2)

Current Price:0.71

Market Cap:$75.56M

Valuation Multiples (3)

P/B Ratio:0.40x

P/S Ratio:0.32x

Peg Ratio:-999.00x

Enterprise Metrics (2)

Enterprise Value:$65.33M

Pfcf Ratio:2.51x

Price Action & Momentum (3)

12-1 Momentum:

-81.2% (2th pctile)

📈 Click to view full DH Momentum analysis →

Momentum Percentile:2 / 100

% of 52-Week High:16.4%

B. Profitability Assessment

Return Metrics (5)

ROE:

-58.6%

📊 Click to view full DH ROE analysis →

ROA:-26.9%

Roic:

-102.7%

📊 Click to view full DH ROIC analysis →

Reinvestment Rate:10.5%

Fundamental Growth Rate (g):-10.8%

Margin Analysis (3)

Operating Margin Ttm:-104.6%

Net Margin Ttm:-72.3%

Ebitda Margin:-89.5%

TTM Performance (3)

Gross Margin Ttm:75.2%

Operating Margin Ttm:-104.6%

Net Margin Ttm:-72.3%

Yield Metrics (3)

Earnings Yield:-$257.53

Owner Earnings Yield:$39.91

Dividend Yield:0.0%

C. Log-Linear Regression Growth Trends

Earnings Surprise (SUE) (3)

Earnings Surprise (SUE):

+0.15

📊 Click to view full DH Earnings Surprise analysis →

EPS Surprise vs Expected:71.8%

Latest Earnings Filed:2026-08-10

Revenue Growth (Linear) (1)

Revenue Growth Rate (Linear):-1.4%

Cash Flow Growth (Linear) (2)

Free Cash Flow Growth Rate (Linear):0.5%

Operating Cash Flow Growth Rate (Linear):-8.8%

D. Financial Stability

Liquidity Ratios (3)

Current Ratio:1.86x

Quick Ratio:1.86x

Cash Ratio:1.32x

Leverage Analysis (3)

Debt To Equity Ttm:0.08x

Debt-to-Equity Ratio:0.08x

Debt To Ebitda:-999.00x

Coverage Ratios (2)

Interest Coverage Ratio:-20.16x

Times Interest Earned:-20.16

Capital Structure (4)

Working Capital:111,034,000.00

Cash And Cash Equivalents:170,866,000.00

Long Term Debt:$151.89M

Net Debt:-$10.23M

DIVISION II: FINANCIAL STATEMENTS ANALYSIS

A. Income Statement Analysis

Revenue Components (2)

Revenue TTM: $232.70M

Linear Growth: -1.4%

📊 Click to view full DH Revenue analysis & methodology →

Cost Of Revenue Ttm:$57.61M

Profitability Breakdown (2)

Gross profit TTM: $175.09M

Linear Growth: -4.6%

📊 Click to view full DH Gross Profit analysis & methodology →

-$243.35M

Bottom Line Performance (3)

-$168.20M

Income Before Tax:-$238.05M

Ebitda Ttm:-208,196,000.00

Operating Expenses (5)

Operating Expenses:418,446,000.00

R And D Expense:30,762,000.00

Sga Expense:49,575,000.00

Income Tax Expense:-$3.31M

Interest Expense:11,122,000.00

Expense Ratios (3)

R And D To Revenue Percentage:55.7%

Sga To Revenue Percentage:89.8%

Ebitda Margin:-89.5%

B. Balance Sheet Analysis

Asset Composition (5)

Total Assets:$496.83M

Current Assets:$240.10M

Ppe Net:14,753,000.00

Goodwill:0.00

Intangible Assets:$222.72M

Liability Structure (4)

Total Liabilities:308,967,000.00

Current Liabilities:129,064,000.00

Long Term Debt:$151.89M

Short Term Debt:$8.75M

Equity & Capital (3)

Equity:$187.87M

Retained Earnings:-$923.55M

Common Stock:0.00

Working Capital Items (3)

Accounts Receivable:30,970,000.00

Inventory:0.00

Accounts Payable:23,787,000.00

Special Items (2)

Contract Liabilities:89,342,000.00

Stock Based Compensation:5,254,000.00

C. Cash Flow Analysis

Operating Activities (2)

Operating cash flow TTM: $39.28M

Linear Growth: -8.8%

Free cash flow TTM: $27.06M

Linear Growth: 48.0%

📊 Click to view full DH Free Cash Flow analysis & methodology →

Investment Activities (2)

Investing Cash Flow:-$6.22M

Capital Expenditures Ttm:12,216,000.00

Financing Activities (3)

Financing Cash Flow:-$10.88M

Dividends Paid Ttm:0.00

Stock Repurchase:0.00

Capital Transactions (3)

Common Stock Issuance:0.00

Long Term Debt Issuance:$0.00

Long Term Debt Repayments:$2.19M

Non-Cash Items (1)

Depreciation Amortization Ttm:35,157,000.00

DIVISION III: OPERATIONAL METRICS

A. Per Share Analysis

Earnings Per Share (3)

EPS (Basic TTM):-1.65

-$1.65

Earnings Per Share Ttm:-$1.59

Revenue & Cash Per Share (3)

Sales Per Share Ttm:2.20

Operating Cash Flow Per Share:$0.51

Fcf Per Share Ttm:0.26

Book Value & Capital (2)

Book Value Per Share:$1.78

Cash Per Share:1.61

Dividend Policy (1)

Dividend Payout Ratio:-999.00x

B. Operational Efficiency

Asset Utilization (2)

Asset Turnover Ttm:0.37x

Working Capital Turnover Ttm:2.10x

Receivables Management (2)

Receivables Turnover Ttm:7.51x

Days Sales Outstanding Ttm:48.58

Inventory Management (2)

Inventory Turnover Ttm:-999.00x

Days Inventory Outstanding Ttm:-999.00

Payables & Cash Cycle (2)

Days Payable Outstanding:150.70

Cash Conversion Cycle:-1,101.13

C. Quality & Risk Metrics

Financial Quality Scores (2)

Financial Strength Score:40.00

Quality Score:40.00

Market Metrics (2)

Beta:0.00x

Volatility Category:unknown

DIVISION IV: INVESTMENT ANALYSIS

A. Value Investment Framework

Owner Earnings Analysis (3)

Owner earnings TTM: $27.06M

Linear Growth: 47.8%

📊 Click to view full DH Owner Earnings analysis & methodology →

Owner Earnings Per Share:$0.26

Owner Earnings Yield:$39.91

Growth Assessment (1)

Owner Earnings Growth Rate:$0.48

Damodaran Growth Analysis (2)

Reinvestment Rate:10.5%

Fundamental Growth Rate (g):-10.8%

Intrinsic Value Models (1)

Intrinsic Value:

$335.18M

📊 Click to view full DH DCF valuation →

Margin of Safety (1)

Margin Of Safety:

77.5%

📊 Click to view full DH valuation analysis →

Return Scenarios (2)

Theoretical 5-Year Return:

38.3%

📊 Click to view full DH expected return analysis →

Forward Expected Return (Yield + Growth):

29.2%

📊 Click to view full DH expected return analysis →

Investment Assessment (1)

Buffett Assessment:Excellent margin of safety

B. Log-Linear Regression Growth Analysis

Growth Rates (Log-Linear Regression) (1)

Revenue Growth Rate (Linear):-1.4%

Cash Flow Growth Rates (2)

Free Cash Flow Growth Rate (Linear):0.5%

Operating Cash Flow Growth Rate (Linear):-8.8%

Other Growth Rates (3)

Gross Profit Growth Rate (Linear):-4.6%

Book Value Growth Rate (Linear):-42.5%

Owner Earnings Growth Rate:$0.48

C. Company Profile & Context

Corporate Information (6)

Symbol:DH

Company Name:Definitive Healthcare Corp.

Sector:Technology

Industry:Software

Exchange:NASDAQ

Country:United States

Market Classification (3)

Market Cap Category:N/A

Price Category:penny

Volume Category:N/A

Share Structure (3)

Shares Outstanding:105.81M

Shares Outstanding Basic:105.81M

Shares Outstanding Diluted:105.81M

Data Processing Info (3)

Processing Version:v3.0

Last Updated:2026-08-22 03:38:14 UTC

Data Timestamp:2026-08-19T19:57:03.343435